You are here

  • Home
  • Archive
  • Volume 80, Issue 10
  • Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases

Article metrics

Article menu
Letter
Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases
Free

 

Online download statistics by month:

Online download statistics by month: August 2021 to March 2023

AbstractFullPdf
Aug 202113831381258
Sep 202126282619417
Oct 202117791762143
Nov 2021972946128
Dec 202175373896
Jan 2022612608121
Feb 202223622056
Mar 202217716259
Apr 202217416534
May 202215315354
Jun 202212011423
Jul 2022969210
Aug 2022989919
Sep 202210410329
Oct 2022978825
Nov 2022564819
Dec 2022676421
Jan 2023646425
Feb 2023828213
Total965195081550